期刊文献+

原因不明性复发性流产91例主动免疫治疗效果分析 被引量:8

Lymphocyte active immunotherapy in 91 cases with unexplained recurrent spontaneous abortion
下载PDF
导出
摘要 目的探讨原因不明性复发性流产(URSA)行主动免疫治疗的疗效及免疫细胞含量的变化特征。方法应用荧光染色和流式细胞技术,分别对2011年1月至2012年8月在安徽医科大学第一附属医院产前诊断中心行淋巴细胞主动免疫治疗的91例URSA患者治疗前后淋巴细胞坏死率及CD3、CD4、CD8及NK细胞比率进行测定;并随访其妊娠结局。结果 79例成功妊娠至12周胎盘形成以后,12例在孕12周以前再次流产,成功率86.81%;治疗后CD3、CD4和NK细胞比例明显下降,CD8及淋巴细胞坏死率显著上升,差异具有统计学意义(P<0.05)。结论淋巴细胞主动免疫治疗对于URSA具有显著的疗效,NK细胞的降低有利于妊娠成功。 Objective To investigate the effectiveness of lymphocyte active immunotherapy in patients with unexplained recurrent spontaneous abortion and the changes of immune cells before and after the treatment as well as the impact on subsequent pregnancy. Methods Fluorescence staining and flow cytometry were used to determine cell nercrosis of lymphocytes CD3, CD4, CD8 and NK cell percentage in 91 unexplained recurrent spontaneous abortion patients between Jan 2011 and Aug 2012 in the First Affiliated Hospital of Anhui Medical University; meanwhile the patients were followed up. Results Among the patients, 79 cases were pregnant successfully to 12 weeks, but 11 had a miscarriage before 12 weeks, and the success rate of active immunotherapy was 86.81%. CD3, C D4 and NK cells declined, and the necrosis rate and CD8 sub - type ratio increased after treatment ( P 〈 0. 05 ; P 〈 0. 05 ). The difference was statistically significant. Conclusion Lymphocyte active immunotherapy is effective for unexplained recurrent spontaneous abortion, and the reduction of NK cells may be helpful for the development of pregnancy.
出处 《安徽医学》 2013年第8期1085-1088,共4页 Anhui Medical Journal
关键词 复发性流产 主动免疫治疗 NK细胞 Recurrent spontaneous abortion Active immunotherapy NK cell
  • 相关文献

参考文献20

  • 1Asher B,Ronit R,Shimon A ,et al. Two vs. three or moreprimary recurrent pregnancy losses - are there any differ-ences in epidemiologic characteristics and index pregnancyoutcome [ J]. Perinat Med,2012,40(3) ,365 -371.
  • 2The investigation and treatment of couples with recurrent first-trimester and second - trimester miscarriage. RCOG Green-top Guideline, 2011,17(4) :1 - 18.
  • 3王永霞.复发性自然流产的病因研究进展[J].中国全科医学,2012,15(26):3086-3088. 被引量:16
  • 4Niederkom JY. The lessons of immune privilege[ J]. NatureImmunology ,2006,7(4) :354 -359.
  • 5Pandey MK, Agreawal S. Induction of MLR - Bf and protec-tion of fetal loss a current double blind randomized trial ofpaternal lymphocyte immunization for women with recurrentspontaneous abortion [ J]. Int Immumopharmacol,2004,4(2):289 -298.
  • 6Samstein RM,Josefowicz SZ,Arvey A,et al. Extrathymicgeneration of regulatory T cells in placental mammals miti-gates maternal - fetal conflict [ J] . Cell,2012,150 (1 ) : 29- 38.
  • 7Williams Z. Inducing tolerance to pregnancy [ J]. N Engl JMed ,2012,367(12) :1159 -1161.
  • 8Shi HB,Wen S . Increased expression of Toll - like receptor3 in decidual natural killer cells of patients with unexplainedrecurrent spontaneous miscarriage[ J]. Eur J Obstet GynecolReprod Biol.2012,165(2) :326 -330.
  • 9Karami N, Boroujerdnia MG, Nikbakht R,et al . Enhance-ment of peripheral blood CD56dim cell and NK cell cytotox-icity in women with recurrent spontaneous abortion or in vitrofertilization failure[ J]. J Reprod Immunol,2012,95( 1 -2):87 - 92.
  • 10Verma PK, Prakash S, Parveen F,et al. Genetic associationof adipokine and UCP2 polymorphism with recurrent miscar-riage among non - obese women [ J]. Reprod Bio Med Online,2012,25(2) : 527 -535.

二级参考文献35

  • 1张元珍,彭倩.母儿ABO血型不合的中西医结合治疗——附11例临床观察[J].湖北中医杂志,1994,16(2):8-9. 被引量:6
  • 2王红,曹缵孙,杨兆瑞,毛文军,陈晓燕.黄体功能不全与生殖激素的关系[J].中国实用妇科与产科杂志,1995,11(1):21-23. 被引量:15
  • 3Wilezynski JR. Immunological analogy between allografl rejection, recurrent abortion and pre-eclampsia--the same basic mechanism? Hum Immunol, 2006, 67:492-511.
  • 4Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update, 2009, 15:517-535.
  • 5Williams LM, Rudensky AY. Maintenance of the Foxp3- dependent developmental program in mature regulatory T ceils requires continued expression of Foxp3. Nat Immunol, 2007, 8 : 277-284.
  • 6Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature, 2007. 445:766-770.
  • 7Inoue N, Watanabe M, Morita M, et al. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol, 2010, 162:402-406.
  • 8Gao L, Li K, Li F, et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci, 2010, 57:51-56.
  • 9Xu Han, Guangming Bao, Yifeng Zhou. Foxp3 rs2294021polymorphism contributes to the susceptibility to breast carcinoma. Chinese-German Journal of Clinical Oncology, 2010, 9:253-257.
  • 10Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CIM + CD25 + regulatory T cells. Nat Immunol, 2003, 4:330-336.

共引文献31

同被引文献106

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部